Supralex

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supralex

Property Description
Active Ingredient Cephalexin (INN)
Form Capsule, Tablet, Oral Suspension
Pharmacological Class Beta-Lactam Antibiotic, First-Generation Cephalosporin
Common Use Anti-infective agent (Treatment of bacterial infections)
Origin Semisynthetic

Supralex: Identity and Pharmacological Classification

Supralex is a prescription-only medicine (Rx) containing the active ingredient Cephalexin (also known as Cefalexin), which is fundamentally classified as a semisynthetic compound belonging to the beta-lactam antibiotic family. Cephalexin is recognized as a first-generation cephalosporin and a specific antimicrobial agent used in human medicine via the oral administration route.

The Supralex brand utilizes this single active component in its formulations, distinguishing it from combination products. Its first-generation classification is clinically recognized for targeting common susceptible pathogens, differentiating its therapeutic focus from broader-spectrum, later-generation cephalosporins.


Composition, Form, and General Purpose

The composition of Supralex centers entirely on the single active ingredient, Cephalexin, prepared for ingestion in various drug forms. The general purpose of this medicine is to act as a definitive anti-infective agent against bacterial infections caused by susceptible microorganisms. This medication exerts an antimicrobial action against specific bacterial pathogens, such as clearing pathogenic bacterial growth.

Supralex is available for oral administration in solid formats like the capsule and tablet, as well as a liquid oral suspension prepared from a powder for oral suspension. This manufacturing choice ensures the medication is accessible to different patient groups, including those requiring liquid forms.


Mechanism and Therapeutic Type

Cephalexin is designated as a first-generation cephalosporin due to its specific chemical structure, which influences the range of bacteria it targets. Its primary physiological action is bactericidal, meaning it is designed to kill susceptible bacteria directly.

The mechanism relies on inhibiting bacterial cell wall synthesis, a vital function for the microbe's survival. By targeting the structures necessary for the cell wall, the drug compromises the structural integrity of the organisms, leading to the elimination of the pathogens. This bactericidal action is the foundation of its general purpose as an effective anti-infective agent.

Regulatory References

  1. Cephalexin: MedlinePlus Drug Information
  2. CEPHALEXIN tablet - DailyMed

What side effects are possible with Supralex?

Possible Side Effects and Safety Information

The safety profile for this medication (corresponding to escitalopram in official regulatory documents) details adverse reactions by frequency and organ system. The most Very Common (ge 10% incidence) side effects reported include headache and nausea. Other Common (1%-10% incidence) reactions involve the nervous, psychiatric, gastrointestinal, and reproductive systems, such as insomnia, somnolence, increased sweating, diarrhea, constipation, and sexual dysfunction (e.g., decreased libido and ejaculation disorder in males).


Serious and Clinically Significant Adverse Reactions

Official regulatory labeling includes a Boxed Warning regarding the increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults (up to age 24) when starting therapy or following dose changes. Other serious or clinically significant adverse reactions include the potential for Serotonin Syndrome, seizures (requiring caution in patients with a history of seizures), and Angle Closure Glaucoma.

Cardiovascular risks include a dose-dependent increase in QT prolongation, which can lead to a fatal heart rhythm abnormality, and the drug is contraindicated in patients with pre-existing long QT syndrome. Hyponatremia (low sodium levels) has been reported, particularly in the elderly, and requires caution.


Restrictions and Specific Population Safety Notes

The medication is contraindicated for use with Monoamine Oxidase Inhibitors (MAOIs). Precautions are required for patients with a history of bipolar disorder due to the risk of activating mania or hypomania. Use late in pregnancy may be associated with an increased risk of Persistent Pulmonary Hypertension of the Newborn (PPHN) and neonatal complications. Patients must be monitored for symptoms of discontinuation syndrome upon dose reduction or cessation, necessitating a gradual taper.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with this medication, whether resulting from a single, large ingestion or from repeated high doses over time (supratherapeutic doses), poses a significant risk of severe hepatic injury, which can lead to acute liver failure and potentially death. This liver-related toxicity is the primary life-threatening outcome associated with an overdose.

Clinical Manifestations and Risk

Symptoms of serious liver damage from an overdose may not be immediately apparent and can be delayed by several hours or days. A critical factor in managing an overdose is this delay in clinical presentation, as significant, life-threatening damage may be occurring internally even if the individual initially feels well.

Risk factors that can increase the potential for severe toxicity include pre-existing liver disease and chronic alcohol use.

Required Emergency Action

Immediate medical attention must be sought following any suspected overdose, even if the individual has no noticeable symptoms. The standard treatment for overdose involves the prompt administration of a specific antidote, N-acetylcysteine.

Regulatory information emphasizes that the antidote’s protective effect against liver injury is most effective when treatment is initiated as quickly as possible, specifically within eight hours of ingestion. Delays in seeking emergency medical help significantly reduce the effectiveness of this vital treatment.

Therapeutic Uses of Supralex

What Supralex Treats: Main Uses and Benefits

Supralex (Cephalexin) is primarily used to provide anti-infective support by addressing susceptible bacterial infections across several key domains. This medication is commonly used to treat infections of the skin, ears, respiratory, and urinary tracts. Its use is applicable within clinical settings that involve acute or disruptive symptom patterns, which supports the patient during difficult episodes by easing distress and helps contribute to improved comfort during acute episodes.

It is applied across domains where additional symptomatic support is needed, including skin and soft tissue infections (like cellulitis and abscesses), upper and lower respiratory infections (such as pharyngitis and tonsillitis), Otitis Media, and genitourinary tract infections (including cystitis). It helps manage groups of symptoms that may become intense or disruptive, such as fever, localized pain, swelling, and burning urination. This therapeutic action helps address acute manifestations of discomfort.

Supralex is also considered relevant for use in specific clinical scenarios, such as certain bone infections caused by susceptible organisms and for prophylaxis—used in scenarios where additional management of discomfort is required—during certain procedures. This application assists with maintaining functional stability and supports patients during episodes of heightened discomfort.


Quick Fact: Managing Inflammatory Symptoms Supralex is used to manage symptoms related to inflammatory or irritative states, which typically manifest as localized redness, tenderness, and pain associated with the infection.

Regulatory References

  1. Cephalexin: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility Map: Official Regulatory Information

The eligibility for Supralex (Cephalexin) is defined by strict regulatory criteria, outlining populations that are contraindicated, require conditional use, or have age-related limitations.

Absolute Prohibition

Category Regulatory Status
Hypersensitivity Contraindicated in patients with a known allergy to Cephalexin or any other cephalosporin-class antibiotic.

Conditional Use and Restrictions

Population Group Required Caution/Restriction
Impaired Renal Function Use requires caution and close monitoring; safe dosage may be lower than generally recommended due to renal elimination.
History of Penicillin Allergy Use requires caution due to the documented risk of partial cross-hypersensitivity with beta-lactam drugs.
Gastrointestinal Disease Use requires caution in patients with a history of colitis or other significant gastrointestinal issues.
Pregnancy/Lactation Use during pregnancy (Category B) is conditional; excretion into breast milk requires caution during lactation.

Age-Related Eligibility

Age Group Regulatory Status
Adults and Children > 1 Year Use is generally established for labeled indications.
Infants < 1 Year Safety and effectiveness are not established for various infections in this age group, according to regulatory documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Supralex (Cephalexin) has officially documented interactions that primarily affect drug elimination, drug exposure, and certain physiological processes, according to regulatory labels.

Documented Exposure and Elimination Interactions

Interacting Substance Official Interaction Pattern
Probenecid Inhibits the renal excretion of Cephalexin, which results in increased and sustained plasma concentrations of Supralex. Co-administration is generally not recommended.
Metformin Increases Metformin plasma concentrations and decreases its renal clearance. Regulatory monitoring is necessary for this combination.
Zinc (Supplements) May reduce the bioavailability of Cephalexin through interference with absorption. Administration must be separated by three hours or more to limit this effect.

Pharmacodynamic and Population Considerations

Regulatory warnings exist for pharmacodynamic interactions with specific drug classes. The combination with oral anticoagulants (e.g., Warfarin) is associated with a risk of prolonged prothrombin time, necessitating close monitoring in at-risk patients, such as those with impaired liver or kidney function. A potential for higher nephrotoxicity is noted when Cephalexin is co-administered with highly potent diuretics (e.g., Furosemide) or other nephrotoxic antibiotics. Furthermore, official regulatory information specifies that patients with markedly impaired renal function require longer monitoring for drug interactions due to delayed clearance of Cephalexin.

Food intake may cause a delayed and slightly reduced absorption of Cephalexin.

Mechanism of Action

Dual Serotonin and Norepinephrine Modulation

Supralex functions as a dual reuptake inhibitor, primarily targeting the Serotonin Transporter (SERT) and the Norepinephrine Transporter (NET) in the central nervous system. By blocking the activity of these proteins on presynaptic neurons, the drug prevents the rapid clearance of serotonin and norepinephrine from the synaptic cleft. This foundational action leads to a sustained increase in synaptic monoamine concentration, thereby enhancing signal transmission across affected neural pathways.


Pathway Modulation and Adaptive Regulation

The enhanced monoamine availability specifically reinforces the activity of the body's descending inhibitory pathways, particularly those involving norepinephrine that project from the brainstem to the spinal cord. This results in the physiological consequence of increased antinociceptive signaling and modulation of afferent nociceptive input. Furthermore, the chronic elevation of synaptic monoamines drives neuroplastic changes, such as receptor desensitization, which results in the long-term adaptive modulation of the neural networks and activity baseline over time.

Dosage and Administration Information

How to Use Supralex: Official Administration Guidelines

Supralex (Cephalexin) is approved exclusively for oral administration in the form of capsules, tablets, or as a powder for oral suspension. The official instructions for use define the required dose, frequency, and duration of therapy.

The standard adult dosing regimen requires a total daily dosage ranging from 1 gram to 4 grams, which must be taken in divided doses. For most infections, this translates to either 250 mg every 6 hours (q6h) or 500 mg every 12 hours (q12h). The medication is considered acid stable and may be administered without regard to meals (with or without food).

The length of treatment typically spans 7 to 14 days, based on the type and severity of the infection. Critically, the official instructions mandate a minimum course of 10 days when treating infections caused by beta-haemolytic streptococci.

Special administration rules apply to certain populations. Doses for pediatric patients (aged 1 year or older) are calculated based on body weight, starting at 25 to 50 mg/kg/day in divided doses, with higher ranges (up to 100 mg/kg/day) required for otitis media. Additionally, dose reduction is required for both adults and children with markedly impaired renal function; this adjustment is determined by the patient's creatinine clearance.

The oral suspension formulation requires specific preparation through reconstitution with water and must be shaken well before each use. If a dose is missed, it should be taken as soon as possible, but never doubled if the time for the next scheduled dose is near.

Recent Clinical Evidence

Research evidence / Overview of studies for Supralex

This section summarizes the types of official research available for Supralex (Cephalexin), detailing what has been studied and what remains unclear, based on information from regulators and peer-reviewed scientific literature. This information provides context but does not offer medical advice or personal predictions.


Evidence for Treating Skin and Soft Tissue Infections

The research exploring the use of Supralex for Skin and Soft Tissue Infections (SSTI) includes Randomized Controlled Trials (RCTs). These studies were used in research exploring how symptoms change over time by comparing the medicine to either an inactive substance or to other common antibiotics. The populations observed generally included adults and children presenting with uncomplicated infections in outpatient settings.

Researchers monitored outcomes related to physical discomfort, such as the resolution of infection signs (e.g., redness, warmth, and pain). Some trials reported that patterns observed in the studies related to outcomes measured in patients who received drainage alone. Data show patterns related to the medicine's classification, which contributes to the broader evidence landscape.

What remains uncertain is the optimal duration that the medicine should be used for different sub-types of SSTI; this is an area where research is ongoing. Long-term effects are not fully established, and there is limited information for long-term outcomes such as sustained symptom resolution beyond the short follow-up periods.


Evidence for Urinary Tract Infections and Otitis Media

Supralex was studied for use in Urinary Tract Infections (UTIs) and Otitis Media. For UTIs, studies explored short-term symptom changes and often involved Multi-centre Randomized Trials that primarily focused on optimizing the length of treatment. The populations included adults with uncomplicated conditions, as well as specialized trials involving infants and young children with febrile UTIs.

These studies monitored outcomes related to physical discomfort, such as microbiological eradication (clearance of bacteria). Findings described patterns observed in the studies related to outcomes measured when comparing different durations of therapy.

Certainty remains low for some aspects of the clinical evaluation of UTIs. For instance, comparative evidence is lacking from large contemporary trials that would compare this medicine directly against a placebo for initial evaluation in uncomplicated adult cystitis. Regarding both UTIs and Otitis Media, long-term effects are not fully established concerning the impact on bacterial resistance in the community over time.

Key Studies & References

  1. Cephalexin (oral route): MedlinePlus Drug Information
  2. Determining the optimal duration of oral antibiotic cefalexin treatment for infants and young children with a clinical diagnosis of febrile urinary tract infection (the CURLY trial)

Frequently Asked Questions (FAQ)

Common questions about Supralex (FAQ)

Q: Are there any specific foods or drinks to avoid while using Supralex?

A: Official information states that this medicine is acid stable and can generally be taken without regard to meals. However, some regulatory and safety information describes a need for separated administration from certain supplements, like zinc, to limit potential interference with drug absorption.


Q: How does the research evidence for Supralex compare to older treatments?

A: Regulatory summaries of the research indicate that studies have explored and compared the outcomes of using Supralex against other common antibiotics and, in some cases, older treatment approaches for various bacterial infections. This comparative data forms part of the evidence used to support the medicine’s authorized use.


Q: What should I tell my doctor about before starting Supralex?

A: Official regulatory information identifies specific medical histories, such as allergies (especially to penicillins or cephalosporins), that should be known prior to initiating treatment. Caution is also noted for individuals with a history of kidney or liver impairment, a history of colitis, or who are currently taking anticoagulants.


Q: Does Supralex interact with birth control pills?

A: Official guidelines indicate that Cephalexin, the active ingredient in Supralex, is a type of antibiotic that is not listed as requiring additional precautions or restricting the use of hormonal contraceptives like birth control pills.


Q: Can people with liver conditions be prescribed Supralex?

A: Official regulatory documents list hepatic impairment (liver conditions) as a situation requiring caution. Regulatory documents state that patients with such conditions are associated with a need for close monitoring due to the potential for effects like a prolonged prothrombin time, which measures the blood's clotting ability.


Q: Does alcohol consumption present a significant risk while taking Supralex?

A: Regulatory data indicates that there is no direct chemical interaction between the active ingredient in Supralex and alcohol. However, official documents caution that alcohol may increase the severity of certain side effects of the medicine, such as dizziness and drowsiness.


Q: Can Supralex cause changes in mood or personality?

A: Official regulatory documents list serious potential side effects that include temporary changes like confusion and, in rare instances, events like seizures or hallucinations. Some official patient documents also list personality change as a rare serious adverse event.


Q: Can Supralex be stopped abruptly, according to official sources?

A: Official patient information describes that patients should not suddenly discontinue use of the medicine or change the dosage without oversight from a healthcare provider.


Q: What happens if I forget to take my Supralex dose one day?

A: Official instructions exist to guide what is generally recommended following a missed dose. This guidance describes procedures for taking the dose as soon as possible and avoiding doubling the next scheduled dose to make up for the missed one.


Q: Is Supralex considered a controlled substance?

A: Supralex (Cephalexin) is classified as a prescription-only medicine (Rx), meaning it requires a prescription from a healthcare provider. However, it is not classified as a federally controlled substance.


Q: How long does the effect of one dose of Supralex typically last?

A: Pharmacokinetic data from regulatory documents indicates that, following a typical dose, levels of the medicine in the blood remain detectable for up to 6 hours after administration. The elimination half-life, which measures the time for the drug concentration to decrease by half, is approximately 1 hour.


Q: Is it normal to feel a change in energy levels when starting Supralex?

A: Official regulatory documents list unusual tiredness or weakness as a common side effect of the medicine.


Q: Can people with kidney problems use Supralex?

A: Official documents state that the use of Supralex requires caution in patients with impaired renal function (kidney disease). In these cases, a mandatory dose adjustment is required to account for the body's slower ability to clear the medicine.


Q: Is it okay to drive or operate machinery while taking Supralex?

A: Official documents caution that the medicine may cause dizziness or drowsiness in some people. Official documents contain cautions related to driving or operating machinery that are applicable until patients understand how the medicine personally affects them.


Q: What should be done if an allergic reaction to Supralex is suspected?

A: Regulatory advice states that if a serious allergic reaction occurs, the drug should be discontinued and appropriate treatment is generally instituted immediately.


Q: Is there a generic version of Supralex available?

A: Yes, the active ingredient in Supralex, Cephalexin, is a widely established medicine. It is broadly available in generic form, and multiple generic versions have been approved by the FDA and other international regulatory bodies.


Q: Do you have to take Supralex at the same time every day?

A: The official dosing regimen requires taking doses in divided doses at regular intervals, such as every 6 or 12 hours. This indicates the importance of adhering to a consistent schedule throughout the day to ensure the required level of medicine is maintained for treatment.


Q: Why might a doctor stop prescribing Supralex?

A: Regulatory text indicates that discontinuation may be required if certain serious side effects develop. Examples include the occurrence of seizures or evidence of an allergic reaction, as these require immediate medical attention and drug cessation.


Q: Are there different strengths of Supralex tablets/capsules?

A: Yes, the official product labeling confirms that the medicine is available in multiple commercial strengths for capsules and tablets, including common doses such as 250 mg and 500 mg.


Q: Are there specific safety monitoring requirements for patients taking Supralex?

A: Regulatory text advises close monitoring for patients considered at risk, such as those with existing renal or hepatic impairment or those taking anticoagulant therapy. This monitoring often involves checking blood parameters like prothrombin time.


Q: Is Supralex widely used internationally, or only in certain regions?

A: The medicine is approved and regulated by multiple major international governmental bodies, including those in the US, UK, Australia, and Canada. This indicates that it is an established and widely recognized medicine globally.


Q: Can Supralex cause constipation or other digestive issues?

A: Official documents list common gastrointestinal side effects such as diarrhea and abdominal pain. Regulatory warnings also describe serious potential risks, including severe diarrhea caused by an overgrowth of Clostridium difficile bacteria.


Q: Is Supralex known to affect heart rhythm?

A: While uncommon, official adverse event reporting data for Cephalexin has included reports of effects on heart function. This includes reports of bradycardia (a slow heart rate).


Q: Can Supralex make a person feel dizzy or light-headed?

A: Dizziness is listed as a common side effect in some official regulatory documents. Patients should be aware of this possibility, especially when standing up quickly.


Q: What happens if I accidentally take too much Supralex?

A: Official documents describe symptoms associated with potential overdose. These symptoms may include effects such as nausea, diarrhea, blood in the urine, convulsions, or hallucinations.


Q: Is it described anywhere that Supralex is for chronic use?

A: Regulatory documents caution against prolonged use of this medicine. Warnings are in place because extended treatment may lead to an increased risk of overgrowth of nonsusceptible organisms.


Q: Why is Supralex sometimes prescribed alongside another drug?

A: The medicine may be co-prescribed with certain other drugs, not necessarily because of an interaction, but to treat specific types of co-occurring infections or to manage complex conditions based on established medical protocols.


Q: Are there different forms of Supralex (e.g., liquid, tablet)?

A: Yes, the drug is available in capsule, tablet, and oral suspension forms. This manufacturing choice ensures accessibility for different patient groups, such as children or adults who may have difficulty swallowing solid forms.


Q: Can taking Supralex affect fertility?

A: Regulatory-backed reports indicate that studies to determine if Cephalexin affects fertility have not been done in humans. However, available animal studies did not show an effect on fertility.

How should Supralex be stored and disposed of?

The storage and disposal of Supralex (Cephalexin) must adhere to official regulatory conditions to maintain stability.

Storage Requirements

Dosage Form Temperature Requirement Stability Constraint
Capsules/Tablets Store at Controlled Room Temperature (20 C to 25 C) Protect from moisture and high temperatures; keep container tightly closed
Oral Suspension (Reconstituted) Store in a refrigerator (2 C to 8 C) Do not freeze; Discard after 14 days of preparation

Disposal and Safety

  • The medication must be stored in a location that is out of the sight and reach of children.
  • Expired or unused product should be discarded through a drug take-back program or disposed of in household trash according to government guidelines.
  • The medication must not be disposed of by pouring it down a drain or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Supralex found in:

A-Z Index: